Target intelligence / Profile preview

Farnesyl diphosphate synthase pseudogene 8 (FDPSP8)

Target: FDPSP8
Molecular classification: Other (Pseudogene)

Overview

Farnesyl diphosphate synthase pseudogene 8 (FDPSP8) is classified as a pseudogene related to the farnesyl diphosphate synthase (FDPS) gene. Unlike the functional FDPS enzyme, which catalyzes key steps in isoprenoid biosynthesis and cholesterol metabolism[2][4][5], FDPSP8 does not produce a functional protein and is not known to play a role in biological pathways or disease processes. There are no known therapeutic drugs or clinical biomarkers associated with this pseudogene, and it is not considered a target for drug discovery or development.

Other names: Farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase) pseudogene 8FDPSP8

Beyond the preview

Go deeper on Farnesyl diphosphate synthase pseudogene 8 (FDPSP8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Farnesyl diphosphate synthase pseudogene 8 (FDPSP8).

Explore the full profile